{"id":"https://openalex.org/G34429661","display_name":"Optimizing Antiretroviral Use in Aging: Pharmacokinetics, Response, and Toxicity","description":"NARRATIVE By 2015, more than 50% of the HIV-infected population in the United States will be at least 50 years of age, and little is known about the optimal clinical care of aging HIV-infected patients. The goal of this and subsequent research is to identify patient-specific factors modifying antiretroviral response and toxicity. This could lead to specific treatment recommendations for older HIV-infected patients.","funder_award_id":"K23AI093156","funder":{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","doi":"10.13039/100000060"},"funded_outputs":["https://openalex.org/W23433482","https://openalex.org/W1602572527","https://openalex.org/W1973561606","https://openalex.org/W1988583073","https://openalex.org/W1990455141","https://openalex.org/W2024983650","https://openalex.org/W2030812094","https://openalex.org/W2091873536","https://openalex.org/W2105401900","https://openalex.org/W2128725304","https://openalex.org/W2176639474","https://openalex.org/W2307009418","https://openalex.org/W2409055273","https://openalex.org/W2444531050","https://openalex.org/W2564410170","https://openalex.org/W2569623562","https://openalex.org/W2603350119","https://openalex.org/W2767382319","https://openalex.org/W2773229331","https://openalex.org/W2899299145"],"funded_outputs_count":20,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"career_development","funder_scheme":"K23","start_date":"2011-03-01","end_date":"2017-02-28","start_year":2011,"end_year":2017,"landing_page_url":"https://reporter.nih.gov/project-details/8814163","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"JULIE BRUMER","family_name":"DUMOND","orcid":null,"role_start":null,"affiliation":{"name":"UNIV OF NORTH CAROLINA CHAPEL HILL","country":"UNITED STATES","ids":null}},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G34429661","primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8438,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8438,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"institution_awarded":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"updated_date":"2026-10-30T03:00:55.000Z","created_date":"2026-10-09T19:56:01.000Z"}